Allostery Investments LP Cytokinetics Inc Transaction History
Allostery Investments LP
- $69.3 Billion
- Q1 2025
A detailed history of Allostery Investments LP transactions in Cytokinetics Inc stock. As of the latest transaction made, Allostery Investments LP holds 70,000 shares of CYTK stock, worth $2.12 Million. This represents 4.06% of its overall portfolio holdings.
Number of Shares
70,000
Previous 65,000
7.69%
Holding current value
$2.12 Million
Previous $3.06 Billion
7.99%
% of portfolio
4.06%
Previous 3.19%
Shares
2 transactions
Others Institutions Holding CYTK
# of Institutions
408Shares Held
127MCall Options Held
3.66MPut Options Held
900K-
Black Rock Inc. New York, NY14.7MShares$444 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.8MShares$359 Million0.01% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD9.96MShares$301 Million0.26% of portfolio
-
Wellington Management Group LLP Boston, MA7.99MShares$242 Million0.06% of portfolio
-
State Street Corp Boston, MA6.09MShares$184 Million0.01% of portfolio
About CYTOKINETICS INC
- Ticker CYTK
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 94,144,096
- Market Cap $2.85B
- Description
- Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...